INT175683

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.21
First Reported 2003
Last Reported 2003
Negated 0
Speculated 0
Reported most in Body
Documents 1
Total Number 2
Disease Relevance 2.28
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (Lcat) extracellular region (Lcat) transferase activity, transferring acyl groups (Lcat)
lipid metabolic process (Lcat)
Lcat (Mus musculus)
Pain Link Frequency Relevance Heat
Inflammation 8 35.44 Quite Low
metalloproteinase 26 5.52 Low Low
Angina 6 5.00 Very Low Very Low Very Low
aspirin 2 5.00 Very Low Very Low Very Low
Percutaneous transluminal coronary angioplasty 2 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
Rostral ventrolateral medulla 2 5.00 Very Low Very Low Very Low
imagery 2 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 6 99.66 Very High Very High Very High
Atherosclerosis 40 99.16 Very High Very High Very High
Targeted Disruption 2 78.72 Quite High
Hyperlipidemia 8 70.72 Quite High
Disease 22 65.00 Quite High
Thrombosis Related Under Development 20 46.88 Quite Low
Thrombosis 4 42.28 Quite Low
INFLAMMATION 10 35.44 Quite Low
Yersinia Infection 2 29.52 Quite Low
Injury 6 28.76 Quite Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Apolipoprotein AI (apoAI) and lecithin-cholesterol acyltransferase (LCAT) are important factors in the removal of excess cholesterol and the subsequent reduction in the incidence of atherosclerotic lesions (Table 1).
Negative_regulation (reduction) of LCAT associated with atherosclerosis and disorder of lipid metabolism
1) Confidence 0.21 Published 2003 Journal J Biomed Biotechnol Section Body Doc Link PMC323957 Disease Relevance 1.13 Pain Relevance 0
Apolipoprotein AI (apoAI) and lecithin-cholesterol acyltransferase (LCAT) are important factors in the removal of excess cholesterol and the subsequent reduction in the incidence of atherosclerotic lesions (Table 1).
Negative_regulation (reduction) of lecithin-cholesterol acyltransferase associated with atherosclerosis and disorder of lipid metabolism
2) Confidence 0.21 Published 2003 Journal J Biomed Biotechnol Section Body Doc Link PMC323957 Disease Relevance 1.14 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox